Safety and efficacy of novel oral anticoagulants in the setting of atrial fibrillation ablation: Is it time to celebrate the “funeral” of warfarin?

Meta-Analysis of Risk of Stroke or Transient Ischemic Attack With Dabigatran for Atrial Fibrillation Ablation

(2014) Partha Sardar et al.   AMERICAN JOURNAL OF CARDIOLOGY

Periprocedural Stroke and Bleeding Complications in Patients Undergoing Catheter Ablation of Atrial Fibrillation With Different Anticoagulation Management

(2014) Luigi Di Biase et al.   CIRCULATION

Does periprocedural anticoagulation management of atrial fibrillation affect the prevalence of silent thromboembolic lesion detected by diffusion cerebral magnetic resonance imaging in patients undergoing radiofrequency atrial fibrillation ablation with open irrigated catheters? Results from a prospective multicenter study

(2014) Luigi Di Biase et al.   HEART RHYTHM

Rationale and design of VENTURE-AF: a randomized, open-label, active-controlled multicenter study to evaluate the safety of rivaroxaban and vitamin K antagonists in subjects undergoing catheter ablation for atrial fibrillation

(2014) Gerald V. Naccarelli et al.   JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY

Safety of new oral anticoagulants for patients undergoing atrial fibrillation ablation

(2014) Gevorg Stepanyan et al.   JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY

Feasibility and Safety of Uninterrupted Rivaroxaban for Periprocedural Anticoagulation in Patients Undergoing Radiofrequency Ablation for Atrial Fibrillation

(2014) Dhanunjaya Lakkireddy et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Use of Dabigatran for Periprocedural Anticoagulation in Patients Undergoing Catheter Ablation for Atrial Fibrillation

(2013) Mohamed Bassiouny et al.   Circulation-Arrhythmia and Electrophysiology

Continuous warfarin versus periprocedural dabigatran to reduce stroke and systemic embolism in patients undergoing catheter ablation for atrial fibrillation or left atrial flutter

(2013) Daniel W. Kaiser et al.   JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY

Dabigatran in the peri-procedural period for radiofrequency ablation of atrial fibrillation: efficacy, safety, and impact on duration of hospital stay

(2013) Kimitake Imamura et al.   JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY

Dabigatran for periprocedural anticoagulation following radiofrequency ablation for atrial fibrillation: a meta-analysis of observational studies

(2013) Benjamin A. Steinberg et al.   JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY

Nonadherence with INR Monitoring and Anticoagulant Complications

(2013) Daniel M. Witt et al.   THROMBOSIS RESEARCH

Dabigatran vs warfarin for radiofrequency catheter ablation of atrial fibrillation

(2012) Jin-Seok Kim et al.   HEART RHYTHM

Feasibility and Safety of Dabigatran Versus Warfarin for Periprocedural Anticoagulation in Patients Undergoing Radiofrequency Ablation for Atrial Fibrillation

(2012) Dhanunjaya Lakkireddy et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Updated Worldwide Survey on the Methods, Efficacy, and Safety of Catheter Ablation for Human Atrial Fibrillation

(2009) Riccardo Cappato et al.   Circulation-Arrhythmia and Electrophysiology

Incidence and Predictors of Periprocedural Cerebrovascular Accident in Patients Undergoing Catheter Ablation of Atrial Fibrillation

(2009) DANIEL SCHERR et al.   JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY

Prevalence and Causes of Fatal Outcome in Catheter Ablation of Atrial Fibrillation

(2009) Riccardo Cappato et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY